MTBVAC

MTBVAC is a candidate vaccine against tuberculosis in humans currently in clinical trials. It is based on a genetically modified form of the Mycobacterium tuberculosis pathogen isolated from humans. Unlike the BCG vaccine, MTBVAC contains all the antigens present in the strains that infect humans.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.